<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hurst JH</submitter><funding>NICHD NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>Duke Microbiome Center, Children’s Miracle Network Hospitals, and the Translating Duke Health Children’s Health and Discovery Initiative</funding><funding>NIH Career Development Award</funding><funding>National Institutes of Health</funding><funding>Duke Microbiome Center, Children's Miracle Network Hospitals, and the Translating Duke Health Children's Health and Discovery Initiative</funding><funding>NIH HHS</funding><funding>National Science Foundation</funding><pagination>e928-e937</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8903463</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>75(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Children are less susceptible to SARS-CoV-2 infection and typically have milder illness courses than adults, but the factors underlying these age-associated differences are not well understood. The upper respiratory microbiome undergoes substantial shifts during childhood and is increasingly recognized to influence host defense against respiratory pathogens. Thus, we sought to identify upper respiratory microbiome features associated with SARS-CoV-2 infection susceptibility and illness severity.&lt;h4>Methods&lt;/h4>We collected clinical data and nasopharyngeal swabs from 285 children, adolescents, and young adults (&lt;21 years) with documented SARS-CoV-2 exposure. We used 16S ribosomal RNA gene sequencing to characterize the nasopharyngeal microbiome and evaluated for age-adjus</pubmed_abstract><journal>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</journal><pubmed_title>Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.</pubmed_title><pmcid>PMC8903463</pmcid><funding_grant_id>T32-HD094671</funding_grant_id><funding_grant_id>T32GM008555</funding_grant_id><funding_grant_id>K23-AI135090</funding_grant_id><funding_grant_id>DGE-1545220</funding_grant_id><funding_grant_id>K23 AI135090</funding_grant_id><funding_grant_id>T32 HD094671</funding_grant_id><pubmed_authors>Moody MA</pubmed_authors><pubmed_authors>McCumber AW</pubmed_authors><pubmed_authors>Kelly MS</pubmed_authors><pubmed_authors>Hurst JH</pubmed_authors><pubmed_authors>Rodriguez J</pubmed_authors><pubmed_authors>Lugo DJ</pubmed_authors><pubmed_authors>Gurley TC</pubmed_authors><pubmed_authors>Aquino JN</pubmed_authors><pubmed_authors>Turner NA</pubmed_authors><pubmed_authors>Clark JS</pubmed_authors><pubmed_authors>Woods CW</pubmed_authors><pubmed_authors>Rawls JF</pubmed_authors><pubmed_authors>Rotta AT</pubmed_authors><pubmed_authors>Pfeiffer TS</pubmed_authors><pubmed_authors>Denny TN</pubmed_authors><pubmed_authors>Heston SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.</name><description>&lt;h4>Background&lt;/h4>Children are less susceptible to SARS-CoV-2 infection and typically have milder illness courses than adults, but the factors underlying these age-associated differences are not well understood. The upper respiratory microbiome undergoes substantial shifts during childhood and is increasingly recognized to influence host defense against respiratory pathogens. Thus, we sought to identify upper respiratory microbiome features associated with SARS-CoV-2 infection susceptibility and illness severity.&lt;h4>Methods&lt;/h4>We collected clinical data and nasopharyngeal swabs from 285 children, adolescents, and young adults (&lt;21 years) with documented SARS-CoV-2 exposure. We used 16S ribosomal RNA gene sequencing to characterize the nasopharyngeal microbiome and evaluated for age-adjus</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T14:57:23.412Z</modification><creation>2024-11-20T05:54:05.21Z</creation></dates><accession>S-EPMC8903463</accession><cross_references><pubmed>35247047</pubmed><doi>10.1093/cid/ciac184</doi></cross_references></HashMap>